Pesquisar | Friendsspace

Asavdaf Asvd adicionou um novo artigo Outro
2025-10-07 12:06:19 -

Quantifying the Unmet Need: Determining the Addressable Patient Population and Market Size for CAR T-Cell Therapy in India
The emergence of CAR T-cell therapy represents one of the most significant revolutions in oncology, particularly for the treatment of hematological malignancies, and its trajectory in the Indian subcontinent is a tale of immense scientific potential struggling against massive accessibility challenges. India, with its substantial burden of blood cancers, including aggressive B-cell...

0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Asavdaf Asvd adicionou um novo artigo Health
2025-10-30 04:52:19 -

The Impact of Favorable Government Policies and Domestic Innovation on the China CAR T Cell Therapy Market Growth
The phenomenal momentum propelling the China CAR T Cell Therapy Market is fundamentally driven by a national strategy to become a world leader in advanced biopharmaceuticals. Government support is not limited to fast-tracking regulatory approvals but extends to direct funding for research institutions, tax incentives for biotech companies, and the construction of specialized industrial...

0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Rutuja Deshmukh adicionou um novo artigo Outro
2026-07-08 14:40:45 -

Cancer Immunotherapy Market Insights into Monoclonal Antibodies and Cytokine Therapies
The global Cancer Immunotherapy Market was valued at USD 153.3 billion in 2025 and is projected to grow from USD 166.4 billion in 2026 to USD 305.8 billion by 2033, registering a CAGR of 9.0% from 2026 to 2033. North America dominated the global market with the largest revenue share of 43.3% in 2025, primarily driven by the increasing prevalence of cancer, continuous innovation in...

0 Comentários 0 Compartilhamentos 11 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!